Skip to main content
Livermore
Livermore
ZHEN

Allurion Technologies, Inc.

ALURW
Exchange
OTC
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001964979

No open-market purchases or sales by Allurion Technologies, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.

Other share classesALUR

Q3 2025 vs. Q2 2025

How the institutions holding Allurion Technologies, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of ALURW: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders39236−1
Shares5.53M234.9K5.68M+381.6K (+7.2%)
Value$178.4K$7.38K$152.6K−$18.4K (−10.8%)

2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Allurion Technologies, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to ALURW in Q3 2025
InstitutionSharesValue% of portfolio
Clear Street Group Inc.234,454$6.33K0.00%
Two Sigma Securities, LLC51,153$1.38K0.00%
JPMorgan Chase & Co–$50.00%
Root Financial Partners, LLC6$00.00%

Sold out (5)

Institutions that held Allurion Technologies, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of ALURW in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Citadel Advisors LLC11,390$358
Limestone Investment Advisors LP10,950$344
Arena Capital Advisors, LLC- CA1,813$57
Raymond James Financial Inc170$5
Farther Finance Advisors, LLC15$0

Not filed for Q3 2025 yet (2)

Institutions that held Allurion Technologies, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ALURW in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Clear Street LLC234,854$7.37K
Oliver Lagore Vanvalin Investment Group61$2